Functional mapping of brain synapses by the enriching activity-marker SynaptoZip by Ferro, M. et al.
              
City, University of London Institutional Repository
Citation: Ferro, M., Lamanna, J., Ripamonti, M., Racchetti, G., Arena, A., Spadini, S., 
Montesano, G., Cortese, R., Zimarino, V. and Malgaroli, A. (2017). Functional mapping of 
brain synapses by the enriching activity-marker SynaptoZip. Nature Communications, 8(1), 
1229.. doi: 10.1038/s41467-017-01335-4 
This is the published version of the paper. 
This version of the publication may differ from the final published 
version. 
Permanent repository link:  http://openaccess.city.ac.uk/21810/
Link to published version: http://dx.doi.org/10.1038/s41467-017-01335-4
Copyright and reuse: City Research Online aims to make research 
outputs of City, University of London available to a wider audience. 
Copyright and Moral Rights remain with the author(s) and/or copyright 
holders. URLs from City Research Online may be freely distributed and 
linked to.
City Research Online:            http://openaccess.city.ac.uk/            publications@city.ac.uk
City Research Online
ARTICLE
Functional mapping of brain synapses by the
enriching activity-marker SynaptoZip
Mattia Ferro1,2, Jacopo Lamanna 1,2, Maddalena Ripamonti1,2, Gabriella Racchetti1,3, Alessandro Arena1,2,5,
Sara Spadini1,2, Giovanni Montesano1,2,6, Riccardo Cortese4, Vincenzo Zimarino2 & Antonio Malgaroli1,2
Ideally, elucidating the role of speciﬁc brain circuits in animal behavior would require the
ability to measure activity at all involved synapses, possibly with unrestricted ﬁeld of view,
thus even at those boutons deeply located into the brain. Here, we introduce and validate an
efﬁcient scheme reporting synaptic vesicle cycling in vivo. This is based on SynaptoZip, a
genetically encoded molecule deploying in the vesicular lumen a bait moiety designed to
capture upon exocytosis a labeled alien peptide, Synbond. The resulting signal is cumulative
and stores the number of cycling events occurring at individual synapses. Since this functional
signal is enduring and measurable both online and ex post, SynaptoZip provides a unique
method for the analysis of the history of synaptic activity in regions several millimeters below
the brain surface. We show its broad applicability by reporting stimulus-evoked and spon-
taneous circuit activity in wide cortical ﬁelds, in anesthetized and freely moving animals.
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Recent years have witnessed the birth of a variety ofmolecular tools to control or sense neuronal activity (seefor review1–4). The latter family includes several genetically
encoded ﬂuorescent indicators that can detect changes in either
membrane voltage or calcium concentration (see for review5–9).
Ideally, a complete understanding of the physiological role of a
speciﬁc area or circuit would require the ability to map synaptic
transmission independently from the electrical activity of neu-
rons. Following the introduction of FM dyes in the 90s10, there
have been signiﬁcant advances in the development of methods
that can probe synaptic communication11–17, which include
elegant genetically encoded ﬂuorescent indicators of vesicle
exo-endocytosis11,12,14,16,18. The most important inherent con-
straint of these techniques is their limited applicability to the
analysis of the living mammalian brain. This is due to the tran-
sient nature of generated signals, whose detection requires online
optical imaging. Besides the requirement of expensive and com-
plex instrumentations, it can only access, with the necessary
optical resolution, synapses that are no more than a millimeter
below the brain surface, because of reduced light penetration in
tissue19. This warrants the development of alternative approaches
to monitor changes in synaptic activity that could be applied to
brain circuits. Here, we have expanded the repertoire of available
synaptic methods to include a reporter that, due to the binding of
a peptide ligand20, generates a very speciﬁc and stable coiled–coil
interaction21. The output relates to presynaptic bouton activity
and is a long-lasting integration signal reporting the history of
vesicle cycling, hence well-suited for both online and retro-
spective circuit analysis. We provide proof of principle of this
strategy and show here its effectiveness in evaluating activity
changes at the level of individual brain synapses, following in vivo
experimental interventions.
Results
Design and validation of SynaptoZip (SZ). To develop Synap-
toZip, one component of the Velcro coiled-coil heterodimer20,
the Zip module, was fused to the intraluminal C-terminus of
VAMP-2/Synaptobrevin2, followed by a Myc tag. Its ﬂuorescent
variant, eGFP-SynaptoZip (GZ), was generated by adding eGFP
to the cytosolic N-terminus (Fig. 1a). The other component of
Velcro was chemically synthetized for use as soluble SynaptoZip
binder, Synbond (SB; 3.9 KDa; Fig. 1a). Both SynaptoZip variants
(GZ and SZ) expressed in Hela cells were found to be localized in
the endoplasmic reticulum, in the Golgi complex, and in a
population of highly motile vesicles, presumably endocytic vesi-
cles/recycling endosomes, due to their colocalization with inter-
nalized transferrin (data not shown; see below). Immunoblotting
of Hela cells expressing SynaptoZip revealed a major band of
28 KDa for SZ and 55 KDa for GZ, which were recognized by
anti-VAMP2, as well as by anti-Myc antibodies (Fig. 1b; Sup-
plementary Fig. 1a). Interestingly, ﬂuorescent SB directly labeled
the appropriate M.W. bands on blot membranes, and consistent
results were obtained with neuronal extracts (Fig. 1b; Supple-
mentary Fig. 1a, b). To test whether extracellular SB molecules
were competent for SynaptoZip binding and uptake during cycles
of constitutive vesicular recycling, SynaptoZip-expressing Hela
cells were incubated with ﬂuorescent SB molecules (5 nM; SB-
Alexa647), for periods ranging from 1 to 60 min (Supplementary
Fig. 2a, b). SB concentration was selected based on in vitro
binding afﬁnity20 and live binding experiments on Hela cells
(Fig. 1c; Kd= 5.09 nM; N= 36–80; logistic ﬁtting, adj. R2= 0.98).
As shown in Fig. 1d, in a mixture of expressing and non-
expressing cells, SB was selectively internalized in expressors,
following ongoing or constitutive vesicular exo-endocytosis
(Fig. 1d; GZ left; SB and DIC image, right).
Since the pool of SB binding sites in Hela cells should be fairly
stable (within a short-time window), we evaluated the behavior of
SB uptake over time (Supplementary Fig. 2a, b). Speciﬁc SB
internalization in GZ-expressing Hela cells could be detected
already at 1–2 min from its application (1 min: Nexpr= 64, SBexpr
= 0.018± 0.017, Nnon-expr= 49, SBnon-expr= 10−4± 0.0022; mean
± SD; p< 10−4 Wilcoxon rank sum test), and at later time points
its intracellular accumulation increased approaching a plateau
level (Supplementary Fig. 2a, b), presumably because of the
progressive saturation of the cycling sites by elevated constitutive
exo-endocytosis. When cells were magniﬁed, the red SB labeling
could be fully attributed to eGFP-ﬂuorescent endocytic vesicles
expressing SB binding sites (Fig. 1d, insets). Consistent results
were obtained with the eGFP lacking variant SZ (see below). SB-
labeled vesicles showed physiological dynamics characteristic of
endocytic vesicles/recycling endosomes (Supplementary Movie 1).
SB uptake was not seen at 4 °C (data not shown), suggesting the
requirement for constitutive exo-endocytosis22 in SB internaliza-
tion. Chemical ﬁxation (10–15 min, 4 °C, 4% paraformaldehyde,
PFA) did not alter SB retention and a comparable estimate of the
amount of internalized SB could be obtained before and after
ﬁxation (data not shown).
As shown by the histograms (Fig. 1e), SB uptake occurred
essentially by a speciﬁc interaction of SB with the luminal epitope
of GZ, and not by unspeciﬁc ﬂuid phase endocytosis,
because only GZ-positive cells showed a strong and fast
SB uptake signal (Fig. 1d, e; SB 5 nM, 60 min incubation;
N= 320, non-expressing cells; N= 636, GZ-expressing cells;
SBexpr= 0.284± 0.089, SBnon-expr= 0.063± 0.014, mean± SD;
p< 0.01, Kolmogorov–Smirnov test (KS)). Co-application of SB
and antibodies against the intraluminal Myc tag resulted in the
co-localization of both molecules in the same GZ-positive vesicles
(data not shown). After long-term exposure to SB, its uptake
linearly correlated with GZ expression level, both assayed in the
sub-membrane region of Hela cells (Supplementary Fig. 2c),
where constitutive endocytic vesicle recycling takes place. Similar
results were obtained by analyzing individual vesicles (Supple-
mentary Fig. 2d, e). Altogether these results conﬁrm that
SynaptoZip is correctly inserted and oriented in the vesicle
membrane. Exocytosis exposes to the extracellular environment
the C-terminal Zip module which then binds extracellular SB,
leading to its very speciﬁc entrapment in the endocytic vesicle.
Despite continuous constitutive vesicle recycling, pre-bound
SB-Alexa647 (5 nM, O/N incubation, 37 °C) was neither
signiﬁcantly displaced by subsequent application of an excess of
SB-Alexa488 (Fig. 1f, left panel; time lapse imaging; SB-Alexa488,
100 nM, 37 °C, N= 6 cells; p= 0.84, Wilcoxon signed-rank test;
analyzed windows 0–10 vs. 50–60 min), nor spontaneously
lost up to 48 h after its vesicular uptake (Fig. 1f, right panel;
N= 38–74 cells per data point; Pearson correlation: ρ= −0.047,
p= 0.26). This suggests that vesicular SB is not free but it is
bound to GZ in a stable complex, as predicted by Velcro in vitro
stability20. Sequential brief incubations (10 min, 37 °C) with three
different SB ﬂuorescent variants (SB-Alexa488, SB-Alexa568, and
SB-Alexa647, 5 nM each) resulted in comparable macroscopic
patterns of vesicular staining (Fig. 1g). When cumulative
ﬂuorescence distributions from the three sequential epochs were
plotted, these nearly coincided (Fig. 1h; average ﬂuorescence;
N= 92 cells; p≥ 0.26; KS test). In the above experimental
conditions, the absence of a signiﬁcant distortion of the SB
uptake distribution, over time and following repeated incuba-
tions, indicates good assay reproducibility, without saturation of
available SB-binding sites. As a whole, these results show that the
amount of the SZ–SB complex can effectively and quantitatively
report vesicular exo-endocytosis in a cultured cell line, generating
a persistent and reliable functional signal.
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SynaptoZip reports synaptic activity. To test whether this
approach could be applied to monitor synaptic exo-endocytosis,
we expressed GZ in cultured hippocampal neurons and in various
brain regions (hippocampus, visual thalamus, primary visual, and
prefrontal cortices). In all preparations investigated, clear eGFP
ﬂuorescent presynaptic varicosities could be seen. These were
conﬁrmed as bona ﬁde synapses, because of the large extent of
colocalization with pre-synaptic and post-synaptic markers
(Supplementary Fig. 3a, b).
The representative images of Fig. 2 illustrate that in both
hippocampal cultures and acute slices, GZ expressing synapses
are selectively labeled by bath exposure of SB. Indeed, as depicted
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in Fig. 2a (top), in acute hippocampal slices from animals
transduced in the CA3 region, Schaffer collaterals labeling
indicated a very precise colocalization between GZ-positive
synapses and SB uptake sites. The VAMP-2-based design and
the lumenal localization of the SB-binding site (Fig. 1a) suggest
that the most likely mechanism of SB synaptic labeling relates to
the exo-endocytosis of synaptic vesicles. In order to conﬁrm this
hypothesis, we used FM1–43, an established in vitro approach to
study exo-endocytosis of synaptic vesicles23. Separately we
evaluated SB localization inside synapses by super-resolution
microscopy (ground-state depletion, GSD24). At FM1–43 pre-
loaded GZ-expressing synaptic varicosities, evoked presynaptic
activity was found to induce SB labeling and parallel unloading of
FM1–43, thus indicating that both molecules use the exo-
endocytic pathway (N= 6 experiments; an exemplar experiment
is shown in Supplementary Fig. 4a–c). By super-resolution
microscopy we found that the SB synaptic uptake resulted in
the labeling of distinct vesicular structures (Fig. 2b–d), whose
diameter distribution and average value (41.2± 16.2, mean± SD;
N= 428 vesicles from 24 synapses) were found to be fully
consistent with those of synaptic vesicles25.
We then investigated the relation between the level of circuit
activation and SB synaptic uptake. Synaptic uptake of SB was
monitored at synapses belonging to individual axons of GZ
expressing cultured hippocampal neurons, which were stimulated
and recorded from in the whole-cell mode (WC; N= 11
independent experiments). As depicted in the representative
experiment shown in Fig. 2e, f, the elicitation of action potentials
(10 Hz trains, 10 APs each, 4 s inter-train intervals) induced clear
synaptic uptake at GZ-positive boutons in the presence of
extracellularly applied SB-Alexa647 (pale-blue shaded areas in
Fig. 2f; SB 5 nM; 24 °C; N= 18 boutons; see also Supplementary
Movie 2). Without stimulation, spontaneous synaptic uptake
remained fairly low. This is clearly indicated by the drop in the
uptake rate when the elicitation of action potentials was
interrupted (white-shaded areas in the presence of SB in Fig. 2f).
The activity-dependent nature of SB synaptic uptake was further
conﬁrmed in experiments where neurons were bathed in
tetrodotoxin (TTX; 1 µM), which was found to strongly reduce
SB uptake rate (data not shown). Importantly, application of SB
to the extracellular medium or its AP-dependent uptake did not
perturb action potential ﬁring and the electrophysiological
synaptic behavior. The latter conclusion arises from the observed
stability of evoked synaptic currents (Supplementary Fig. 5a, b),
as well as amplitude and frequency of miniature events (mini
frequency and amplitude before and during SB, p= 0.31 and
p= 0.12, respectively; TTX, 1 µM; Supplementary Fig. 5c, d).
Since synapses integrate pre-synaptic and post-synaptic compart-
ments to evaluate the relation between the strength of transmis-
sion and the amount of SB uptake, we conducted a series of dual
electrophysiological recordings from synaptically connected pairs
of neurons (N= 5 pair recordings; Fig. 3a). To modify the
amount of transmitter release and therefore SB uptake, we varied
the presynaptic AP stimulation frequency (0.2–40 Hz). As evident
from the representative experiment shown in Fig. 3a–f, the
increase in stimulation frequency induced a clear facilitation of
excitatory postsynaptic currents (EPSCs) (Fig. 3b, d) and larger
EPSCs were found to correlate with higher increments in synaptic
SB uptake (Fig. 3e). This relationship diverges from a linear
approximation just for very large synaptic currents, indicating a
reduced sensitivity for strong release regimes. In summary, the
vesicular localization of SB and the uptake dependence upon
presynaptic activation strongly support the validity of SynaptoZip
as a tool to measure the degree of synaptic transmission.
SynaptoZip reports evoked activation of brain circuits. The
clear functional signal obtained from synapses in acute brain
slices (Fig. 2a) highlights that SB diffuses inside the brain tissue,
reaching the synaptic cleft. This prompted us to test this method
in the living brain. SynaptoZip was expressed in rat V1 cortex and
medial prefrontal cortex (mPFC) using viral vectors, followed by
the local nano-rate delivery of SB through a glass micropipette
(Supplementary Fig. 6a–d). Thanks to the long-term stability of
the SB–GZ pair (Fig. 1f), the amount of SB uptake could be
determined ex vivo, thus grasping signals even from boutons that
could not be reached with the today available optical techniques.
We found clear evidence for in vivo SB uptake at synapses
(Figs. 4, 5). The efﬁcacy of this approach likely relates to the small
M.W. and therefore diffusibility of the SB peptide, since larger M.
W. tracers (anti-Myc antibodies targeted to the C-terminal
luminal epitope of SZ) did not work in similar conditions (Sup-
plementary Fig. 7a–e). Great care was taken to improve the assay
reproducibility, with a precise location and timing of SB appli-
cation, and by selecting the most appropriate region for image
acquisition based on SB tissue distribution proﬁle (Supplemen-
tary Fig. 8a–c, e; see Methods).
We began by exploiting the rat primary visual cortex (V1),
where circuit activity can be easily controlled by light (Supple-
mentary Fig. 9a–e). With this aim in mind, the visual thalamus
(LGN) was stereotaxically transduced in its dorsal portion
(dLGN; see methods for details), resulting in clear GZ expression
in thalamic neurons and ipsilateral V1 thalamo-cortical synapses
(Fig. 4a–f). These eGFP ﬂuorescing presynaptic varicosities were
located in layer IV and to a smaller extent in deeper as well as in
more superﬁcial cortical layers of the V1 cortex (Fig. 4c–f). In
these experiments, after GZ cortical expression, SB was delivered
into the V1 superﬁcial layers (I–II) (Fig. 4g, Supplementary
Fig. 6a, b).
To test whether SB uptake could be induced by evoked
activation of thalamo-cortical synapses, these animals were either
exposed to visual stimulation with brief light pulses (light
stimulated; pulse width 250 ms, intensity 340 µW/cm2, at 2 Hz
for 15 min) or kept in the dark for the same length of time (ctrl;
Fig. 4h). The light-stimulation protocol was devised in a series of
preliminary experiments aimed at eliciting reproducible
Fig. 1 Design and characterization of SynaptoZip. a Cartoon depicting the reporter system; box diagrams illustrate SZ moieties. S1, S2: spacer sequences;
Zip: Acid-p1. b WB of transfected (GZ, SZ) and non-transfected (Ctrl) Hela cells, detection with anti-VAMP2, anti-Myc epitope tag, anti-GFP antibodies,
and with SB-Alexa647 (see also Supplementary Fig. 1a). c Analysis of Zip-Bond binding in live Hela cells (the red line is the logistic ﬁtting, adj. R2= 0.98,
Kd= 5.09 nM; N0.1nM= 38, N1nM= 65, N2nM= 45, N3nM= 80, N5nM= 59, N10nM= 39, N30nM= 48, N100nM= 36; mean± s.e.m.). d SB uptake in a mixture of
transfected and non-transfected Hela cells (green, eGFP; red, SB and DIC image; SB 5 nM, 1 h incubation). e Histograms of SB ﬂuorescence and their
cumulative representation (Inset; N= 320, non-expressing cells; N= 636, GZ-expressing cells; SBexpr= 0.284± 0.089, SBnon-expr= 0.063± 0.014,
mean± SD; p< 0.01, KS test). f Analysis of the fate of internalized SB in SZ-expressing Hela cells. Left, internalized SB-Alexa647 was not displaced
by excess of SB-Alexa488 (time-lapse imaging, N= 6; mean± s.e.m.). Right, vesicular SB remains up to 48 h from extracellular washout (N5min= 71,
N0.5h= 60, N1h= 47, N1.5h= 60, N2.5h= 53, N3.5h= 73, N5.5h= 42, N6.5h= 39, N21h= 37, N24h= 50, N48h= 47; mean± s.e.m.). g Hela cells expressing
non-ﬂuorescent SZ were incubated sequentially with SB-Alexa488, SB-Alexa647, SB-Alexa568. h Cumulative histograms of cell ﬂuorescence from N= 92
cells as in g, illustrating the labeling similarity among the epochs (p≥ 0.26; KS test). Scale bars, 10 μm, 1 μm inset (d) and 10 μm (g)
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responses with a good balance between ON and OFF phasic
responses, to maximize synaptic cortical activation under
sevoﬂurane anesthesia (Supplementary Fig. 9). In unstimulated
animals, the SB functional signal obtained from GZ-positive
boutons located in layer IV was weak, with few clearly SB
ﬂuorescing synapses, evidently reﬂecting a small degree of
spontaneous tonic OFF activity (a representative experiment is
shown in Fig. 4i, j). This is consistent with the strong inhibition of
spontaneous cortical activity by sevoﬂurane in V1 cortex26.
Following repeated light ON-OFF stimulations, the synaptic SB
uptake was augmented, with a clear increase in the number of SB
ﬂuorescing thalamo-cortical layer IV GZ-positive boutons (a
representative experiment is shown in Fig. 4k, l; see also
Supplementary Movie 3). Our experimental protocol and analysis
approach allowed selecting FOVs for synaptic uptake analysis
located on the ﬂat portion of SB spatial concentration proﬁle
(600–800 µm from microperfusion sites) resulting in low
extracellular SB concentration variability and comparable levels
in non-synaptic areas among the different experimental groups
(Supplementary Fig. 8d; see Methods). Fluorescence histograms
obtained from the above experiments clearly indicate that in the
absence of stimulation the synaptic SB uptake is not distinguish-
able from tissue background (Fig. 4m; N= 233 synapses and N=
93 neighboring non-GZ+ areas, pctrl-background= 0.45, KS test). On
the contrary, ON-OFF light stimulation markedly displaced the
uptake distribution from background (Fig. 4n; N= 177 synapses
and N= 92 neighboring non-GZ+ areas, plight-background< 0.0001,
KS test), as well as from the unstimulated condition (Fig. 4n inset;
plight-ctrl< 0.0001, KS test). This indicates a sharp increase in the
number of active sites by ON-OFF light stimulation. Across
different experiments, while the synaptic expression of the
reporter GZ was found to be comparable (Fig. 4o; GZ expression:
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SB (hot red LUT; SB 5 nM; 60min incubation, 37 °C). c Magniﬁed view of synaptic vesicles loaded with SB. d Analysis of vesicles diameter following
spontaneous uptake of SB (N= 428 SB-labeled vesicles from 24 synapses; 41.2± 16.2, mean± SD). e, f Time-lapse imaging of SB uptake (SB 5 nM, 24 °C;
color map, LUT at the bottom) in a group of boutons along a single axon (cultured hippocampal CA3–CA1 neurons), before and during trains of presynaptic
action potentials (APs). In f, green lines are normalized SB uptake time series for N= 18 individual boutons (same experiment as in e; thick black line is the
average SB uptake trace; blue diamonds correspond to time frames shown in e). The red bar refers to the presence of SB 5 nM in the bath, the blue bar
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present. On top of graph, expanded traces to illustrate SB uptake (black lines; scale bar: 0.05 a.u. vs. 2 min) from 4 out of the 18 boutons (indicated by
white arrowheads in e, GZ), and its rate (green lines, time derivative; scale bar: 0.05 a.u. h−1 vs. 2 min), during the second stimulation epoch. Notice that,
despite the common trend, each synapse shows its own SB uptake dynamics. Scale bars: 4.11 µm (a, e), 400 nM (b), 40 nM (c)
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control, N= 5 rats, 0.1± 0.03; light stimulated, N= 5 rats, 0.11±
0.01; mean± s.e.m.; p= 0.93; two-samples permutation test), the
average number of active thalamo-cortical synapses was sig-
niﬁcantly increased by the ON-OFF light stimulation (Fig. 4p; %
synapses with SB uptake above background: control, 10.7± 5.5%,
Ncontrol= 5 rats; light stimulated, 47.7± 1.9%, Nlight-stimulated= 5
rats; mean± s.e.m.; p< 0.005, two-samples permutation test;
threshold for synapse selection 2 SD of background noise).
Overall, this suggests that GZ can be effectively used to report
stimulus evoked activation of brain circuits occurring in vivo.
SynaptoZip detects enduring activity changes by ketamine. To
further test the applicability of this approach in freely moving
animals, we examined the effect of ketamine on the mPFC.
Previous micro-dialysis experiments have provided evidence that
a single sub-anesthetic dose of ketamine induces neurotransmitter
accumulation in the extracellular space27,28, although the invol-
vement of synaptic exocytosis and the contribution of the
intrinsic mPFC circuitry are not established. Prelimbic mPFC of
adult rats was stereotaxically transduced with GZ in layer V
(Fig. 5a), resulting in the appearance of eGFP ﬂuorescing neurons
and axonal synaptic boutons belonging to the local mPFC cir-
cuitry (layers I–VIa; Supplementary Fig. 10). After 2–3 weeks
from transduction, a bolus of SB was micro-perfused at low rate,
∼700 µm above the GZ–LV injection site (Fig. 5a, Supplementary
Fig. 6c). During this SB perfusion epoch (30 min), run under
sevoﬂurane anesthesia, SB efﬁciently spread and accumulated in
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Fig. 3 Synaptic transmission and SB uptake at hippocampal synapses. a–f Simultaneous electrophysiological and optical recording from a pair of
synaptically connected hippocampal neurons (representative experiment from N= 5 pairs). a Images of the pre-synaptic and post-synaptic cells (left, DIC
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trains applied every 5 s). c A subset of synapses, to illustrate reporter expression (GZ) and the effect of action potential trains on SB uptake (SB).
d Analysis of the strength of synaptic transmission at different presynaptic stimulation frequencies (20–40Hz trains as in b), indicating facilitation of EPSC
amplitude. e Time-course of SB uptake (normalized for its ﬁnal value) for N= 18 synapses belonging to the same axon at variable stimulation frequencies.
f Percent increment of SB uptake for individual trains and synapses (synaptic charge and SB uptake were averaged over trains at the same stimulation
frequency; same synapses shown in e). The green line is the ﬁtting trace with a mono-exponential curve. Notice that the correlation approaches a ceiling
for very high postsynaptic current values. Scale bars: 20 µm (a), 10mV or 25 pA, 100ms (b), 5 µm (c)
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the mPFC (Supplementary Fig. 6d), with negligible synaptic
uptake (Supplementary Fig. 11a, b). At the end of SB delivery
epoch, animals were woken up from anesthesia and left freely
moving for 90 min, set as the observation window for synaptic
activity. To test for the effect of ketamine, we evaluated synaptic
uptake at early and late (72 h) time points after the systemic
injection of a single dose of ketamine (15 mg/kg; i.p. injection). In
all experimental groups, including controls (vehicle injected), the
90 min freely moving epoch resulted in a clear SB uptake in a
large fraction of GZ-expressing mPFC synapses (N= 6 rats for
each condition; ctrl, 84%; ketamine, 92.4%; 72 h after ketamine,
91.5%; Fig. 5c–h), evidently a reﬂection of the strong spontaneous
activity of local prefrontal circuits in the awake state29. Interest-
ingly, this synaptic labeling was still detectable 7 days after SB
uptake (Supplementary Fig. 11c, d), suggesting that, in this time
frame, the previously generated synaptic GZ–SB complex remains
stable. Compared to controls, both ketamine-treated groups
showed a clear augmentation of synaptic SB uptake. At early and
late time points from ketamine treatment, changes in synaptic
uptake affected the entire range of activity levels, with an
homogeneous shift of ﬂuorescence cumulative distributions
(Fig. 5i; Nctrl= 216, Nket= 275, N72hket= 227; pctrl-ket< 0.0001,
pctrl-72hket< 0.0001; pket-72hket= 0.35; KS test, Bonferroni–Holm
(B-H) correction; data from same experiments presented in
Fig. 5c–h). As for V1 cortex, in the mPFC areas where synapses
were analyzed (600–800 µm from the SB injection site) the esti-
mates of SB concentration in non-synaptic areas indicated that
synapses were exposed to similar SB concentrations (Supple-
mentary Fig. 8f). Population data from these experiments showed
that at early times, compared to controls, ketamine almost dou-
bled synaptic SB uptake, an activity change that is still observable
72 h after (Fig. 5j; N= 6 rats for each condition; ctrl, 0.194±
0.022; ketamine, 0.358± 0.015; 72 h after ketamine, 0.317± 0.037;
mean± s.e.m.; pctrl-ket< 0.01; pctrl-72hket< 0.05; pket-72hket= 0.32;
two-samples permutation test, B-H correction; values corrected
for variation in synaptic GZ expression, see Supplementary
Fig. 12a–i and its legend for details about the selection of the
uptake index used in mPFC experiments).
Ketamine is known to increase animal motility30, an effect that
could indirectly drive mPFC activity by enhanced input from
several sensory modalities. At early time points, ketamine was
found to induce a clear increase in locomotion (Supplementary
Fig. 13a–d, g, j, k), characterized by ataxic movements
(Supplementary Fig. 13h, i). However, this behavior was
apparently lost 72 h after ketamine injection (Supplementary
Fig. 13e–k), while the potentiation of synaptic SB uptake persisted
(Fig. 5i, j). Thus, the long-lasting change in mPFC circuit activity
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Fig. 4 Reporting the activation of thalamo-cortical synapses in vivo. a Visual
thalamus (dLGN, dashed area) transduced by GZ lentiviral vector.
b magniﬁed view of transduced dLGN. c GZ-expressing synapses in V1
cortex. d–fMagniﬁed views of layers I, II–III, and IV showing GZ-expressing
presynaptic boutons. g Illustration (left) and merged ﬂuorescent images
(right) of the V1 cortex with sites of GZ expression (green) and SB injection
(red; dashed square indicates a typical ﬁeld for SB uptake analysis; see also
Supplementary Figs. 6, 8). h Time ﬂowchart showing SB perfusion,
sevoﬂurane anesthesia, and dark or dark/light exposure visual stimuli. i–l V1
layer IV from control animals kept in the dark (Ctrl; i, j) or exposed to light-
pulses (light stimulated; k, l), showing GZ expression (i–k) and SB uptake
(j–l). Insets are magniﬁed areas from dashed boxes. Color bars on the right
are ﬂuorescence LUTs. m, n SB ﬂuorescence histograms for unstimulated
control (m; cyan bars; N= 233 synapses and N= 93 neighboring non-GZ+
areas, pctrl-background= 0.45, KS test) and light stimulated (n; red bars;
N= 177 synapses and N= 92 neighboring non-GZ+ areas, plight-background<
0.0001, KS test) GZ-expressing synapses, and for the corresponding
background ﬂuorescence (gray bars; same experiments as i–l). Inset n,
cumulative distributions of synaptic SB uptake for data set in m, n
(plight-ctrl< 0.0001, KS test). o, p Population data from control and light-
stimulated animals for synaptic GZ expression (o; N= 5, p= 0.93; two-
samples permutation test) and activity (p; N= 5, p< 0.005; two-samples
permutation test). Scale bars: 245 μm (a, c, g), 10 μm (b, d–f, i–l)
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synapses. Fluorescence LUTs on the right. i Cumulative distributions of SB uptake from GZ-expressing synapses (Nctrl= 216, Nket= 275, N72hket= 227; pctrl-
ket< 0.0001, pctrl-72hket< 0.0001; pket-72hket= 0.35; KS test, B-H correction; same experiments as in c–h). j Population data for normalized SB synaptic
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permutation test, B-H correction; see also Supplementary Fig. 12). Scale bars: 100 μm (a), 10 μm (c–h)
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induced by ketamine is not explained by increased animal
motility.
Discussion
We have developed a novel synaptic activity reporter, which
operates both in vitro and in vivo, whose integrated signal is
durable and can be acquired not only online but most impor-
tantly by retrospective analysis. Signal integration arises from
speciﬁc binding and trapping into the synaptic vesicle of the
SynaptoZip partner SB, whose synaptic enrichment reﬂects the
number of synaptic exo-endocytic events occurring during an
experimental epoch. This method, which generates reliable
activity estimates, fulﬁlls the demand for a thorough post hoc
analysis of brain synapses. Its application is cost-effective, and can
reach synapses that are outside the grasp of standard optical
imaging methodologies19, hence potentially usable to map the
activity of the whole brain. Our approach is compatible with
immunolabeling and possibly clearing methods (see for review31).
Importantly, SynaptoZip could be combined with neuronal
activity integrators32–34, to solve the functional contribution of
upstream and downstream circuital elements.
Here, we have applied SynaptoZip to the V1 cortex, obtaining
reliable estimates of light-evoked synaptic activity in the anaes-
thetized rat (Fig. 4). Indeed, like other exo-endocytosis
indicators10–17, SynaptoZip generates a synaptic signal that
depends on presynaptic action potential ﬁring (Fig. 2), whose
frequency is strongly modulated at thalamo-cortical synapses by
phasic ON-OFF light stimulations (Supplementary Fig. 9). In the
mPFC this approach was applied to reveal drug-induced changes
in spontaneous synaptic activity in freely moving animals (Fig. 5).
In these experiments we used ketamine, a drug that at sub-
anesthetic doses exerts a rapid antidepressant effect, whose
mechanism and site of action are still highly debated28,35. We
found that the activity of the intrinsic mPFC synaptic network is
rapidly enhanced by a single ketamine administration, a change
that persisted for at least 72 h. This ﬁnding agrees with previous
micro-dialysis experiments, which provided evidence for
ketamine-induced glutamate accumulation in the extracellular
space27,28. By use of SynaptoZip, we show that an enhanced
vesicular release of glutamate at the level of layer V to layers II–III
mPFC synapses is the most likely mechanism behind glutamate
accumulation, which could induce and/or maintain subsequent
plastic changes36 in the mPFC circuitry.
Regarding the design of the SynaptoZip–SB pair, we used the
Velcro coiled-coil heterodimer20 for its very high-binding speci-
ﬁcity and pair stability20,21, but also because the soluble peptide
partner (SB) is small (3.4 KDa), thus favoring an efﬁcient diffu-
sion in brain extracellular spaces and into the synaptic cleft
(Supplementary Fig. 7). In the future it might be interesting to
evaluate alternative peptide pairs with different properties and
binding afﬁnities37. VAMP-2, SynaptoZip vesicular scaffold, has
been previously used in other synaptic activity sensors11,12,14.
VAMP-2 is the most abundant vesicular protein38,39, with a
single transmembrane domain and a very short, presumably inert,
intraluminal segment40. Conceivably, both factors have guaran-
teed the high level of vesicular expression found here, which is
important to avoid a fast saturation of the integrated SB signal. In
addition, because VAMP-2 is a ubiquitous synaptic vesicle pro-
tein, it is present at all synapses independently of their neuro-
chemical phenotype, and SynaptoZip would be well integrated
with the native fusion machinery.
As demonstrated here, our approach works well in vivo,
although some methodological aspects would beneﬁt from ad hoc
future developments. At present, the major technical difﬁculty
relates to the SB delivery phase into the brain tissue, a procedure
that involves extreme accuracy during the experimental and
subsequent analysis phase. Clearly, at a given stimulation rate, the
cumulative index of synaptic activity at each bouton would
depend upon the number of exo-endocytotic events along the
experimental epoch, the experimental parameter that is important
to extract, but also upon the average number of SB molecules
successfully bound at each fusion event. The latter would be
inﬂuenced by SB concentration in the extracellular space (Sup-
plementary Fig. 12d–i), by fusion kinetics16,18 and its modality,
but also by the average number of available binding sites at each
individual vesicle that can be extracted by the expression signal.
In our experimental conditions, the extracellular tracer con-
centration at regions selected for analysis was found to be fairly
constant and comparable among the different groups (Supple-
mentary Fig. 8d, f). Regarding the dynamics of fusion and
retrieval of synaptic vesicles, known to display complex kinetics, a
dissimilar coverage of the different modalities41–44 might occur.
Such limitation might contribute to the shape of the relationship
between SB uptake and synaptic transmission, with some hints of
saturation at very high stimulation frequencies (Fig. 3f). In the
future, it would be important to ﬁnd alternative ways to deliver
SB locally at synapses, but also to test smaller versions of these
tracers. Despite these caveats, since the integrated output
of SynaptoZip clearly correlates with the degree of synaptic
activation (Figs. 2–4; Supplementary Fig. 4 and Supplementary
Movie 2), this ensures that even at this stage, a reliable mapping
of brain synaptic activity can be achieved, a result that cannot be
obtained with any other presently available technique.
Concerning behavioral studies, if more effective ways for the
chronic and timed-controlled delivery of SB to brain synapses
were to be found, the analysis of time-dependent changes in
synaptic activity in freely behaving animals would become fea-
sible. Interestingly, the long-term stability of the vesicular
SynaptoZip–SB complex for at least 1 week (Supplementary
Fig. 11c, d) suggests that multiple chasing with different SB
ﬂuorescent versions could track the fate of synapses and synaptic
vesicles, thus helping to address important queries in behavioral
neuroscience but also in neurobiology45, and in the ﬁeld of circuit
plasticity36. This technology could also be used for the selective
delivery of molecules to active terminals, to tag or remove circuits
involved in speciﬁc behaviors. In the future, following ad hoc
labeling of SB with radioactive isotopes or paramagnetic mole-
cules, our approach could be adapted for in vivo imaging by
animal PET and fMRI. Since antibodies targeting natural intra-
luminal vesicular epitopes46,47 cannot be applied as in vivo
functional probes (Supplementary Fig. 7), we envisage that the
search for small ligands for native synaptic vesicle intraluminal
epitopes may be an important and rewarding future avenue,
capable of extending our approach to naïve animals.
Methods
Research and animal procedures. Research and animal care procedures were
approved by our Institutional Animal Care and Use Committee for Good Animal
Experimentation in accordance with Italian MIUR code of practice for the care and
use of animals for scientiﬁc purposes (IACUC numbers: 576, 541, and 543).
Experiments were performed on Sprague Dawley male rats (150–350 g). Animal
group allocation was known by the investigators. All efforts were devoted to
minimize animal’s distress, pain, and suffering during the entire course of the
experimentation. All animals were caged with free access to food and water ad
libitum and were exposed to 12 h light/dark cycles at 23 °C constant room
temperature.
Constructs and expression vectors. SynaptoZip (SZ) was made starting from a
cDNA clone in pBluescript KS provided by Elferink and colleagues48 carrying the
Rattus norvegicus Synaptobrevin-2/VAMP-2 CDS and 3′UTR. A Bsu36I fragment
containing 231 bp downstream the natural stop codon (TAA, nucleotides 431–433
in Ref. Seq. NM_012663.2) was excised leaving a unique Bsu36I site that abuts the
stop codon. The latter was mutated to a Serine codon (TCT) and a synthetic Bsu36I
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fragment (174 bp) was inserted in frame that codes, in the order, SVPEG (an
adapter) and KGVEPKTYCYYSS (a spacer49), AQLEKELQALEKENAQLE-
WELQALEKELAQ (Acid-p120), EQKLISEEDI (c-Myc tag), ending with an ad hoc
stop codon (TGA). The remaining 3′UTR (1300 bp) was left intact and in place.
For the expression vector of the non-ﬂuorescent variant SynaptoZip (SZ) a
HindIII-SacI fragment was transferred into pBeta-Actin, kindly provided by
Andrew Matus. The ﬂuorescent variant eGFP-SynaptoZip (GZ) was obtained by
in-frame fusion to eGFP at the EcoR1 site of pEGFP-C2 (Clontech); it comprises 13
foreign codons from the vector MCS and lacks the ﬁrst VAMP-2 codon. For
insertion into the lentiviral (LV) transfer vector, kindly provided by L. Naldini50,
an Age1-Sal1 fragment containing GZ was used to replace the pre-existing eGFP,
resulting in GZ-LV transfer vector. LV particles were produced as previously
described50 and stock titers (~109 TUml−1) determined. All constructs were con-
ﬁrmed by DNA sequencing (Euroﬁns Genomics, Italy). SB peptide was produced
by synthesis (CGGAQLKKKLQALKKKNAQLKWKLQALKKKLAQ; JPT Peptide
Technologies GmbH, Berlin, Germany) and ﬂuorescent dyes were conjugated to
the terminal Cys (Alexa Fluor Dyes®: 488, 568, 647; Thermo Fisher Scientiﬁc).
Experiments with Hela cells. Hela cells (ATCC® CCL-2™; LGC Standards S.r.l.,
Italy; STR authenticated), regularly tested to be mycoplasma free, were grown on
glass coverslips (25 mm diameter) or plastic petri dishes (10 cm diameter) at 37 °C,
in 5% CO2 humidiﬁed incubator in DMEM supplemented with 10% (v/v) FCS,
GlutaMax, and antibiotics. For SZ expression, cultures were transfected with vector
DNA using Lipofectamine 2000 (Invitrogen) or transduced with GZ-LV vector pre-
diluted in culture medium (ﬁnal titer for transduction in vitro: ~106 TUml−1).
Incubation with SB (0.1–100 nM) was run either in DMEM at 37 °C 5% CO2 or in
oxygenated Tyrode solution at 23 °C. For long-term experiments, DMEM was
supplemented with 1% FCS (v/v). For ﬁxed samples, at the end of incubation, cells
were extensively washed ﬁrst with cold Tyrode solution containing 1% BSA, fol-
lowed by PBS and PFA 4% (30 min, 4 °C).
Western blot analysis. Lysates from Hela cells (50 µg) and neurons (20 µg) were
subjected to SDS-PAGE (14%) then transferred onto nitrocellulose ﬁlters (0.22
µm). Protein bands were detected by ﬂuorescent SB, Mouse anti-c-Myc mono-
clonal 9E10 (Abcam), Mouse anti-VAMP2 monoclonal (Synaptic System) or
Rabbit anti-GFP (Merck Millipore) primary antibody, the latter three followed by
the respective peroxidase-conjugated secondary antibody (Biorad). Chemilumi-
nescence was with Hyperﬁlm ECL (GE-Healthcare Bio-Sciences), signal acquired
by Personal Densitometer (GE-Healthcare Bio-Sciences). For detection with SB,
ﬁlters were incubated (5 nM SB-Alexa647 in blot solution, for 1 h at 24 °C) then
washed (blot solution, ﬁve washes, 10 min each), and ﬂuorescence detected by
Typhoon800 (GE-Healthcare Bio-Sciences).
Neuronal cultures. Primary postnatal neuronal cultures were prepared from
Sprague Dawley rats (2–5 days old) as previously described46,51. In brief, P2–P5
rats were rapidly decapitated and hippocampi dissected out. Dissociated neurons
were grown on poly-L-ornithine (10 µg ml−1) and Matrigel (1:50 dilution; Becton,
Dickinson and Company, NJ) coated 35 mm petri dishes or glass coverslips
(25 mm). Neurons were maintained in a CO2 incubator (5% CO2, 37 °C; Heraeus
Instruments GmbH, Hanau, Germany) using a modiﬁed minimum essential
medium with Earle’s salts (Gibco®, Life Technologies) in 5% dialyzed FCS (Gibco®,
Life Technologies). Every 3 days one-third of the culture medium was replaced
with fresh medium supplemented with cytosine β-D-arabinofuranoside (Ara-C;
2.5–5 µM) to prevent excessive glial cells proliferation. For GZ expression, neurons
were transduced with GZ-LV vector pre-diluted in culture medium 1 h after
plating.
Acute hippocampal slices. Acute hippocampal slices were obtained from Sprague
Dawley rats (150–200 g) previously transduced (2 weeks before) with GZ-LV in the
right hippocampus CA3 (stereotaxic coordinates: 3.8 mm mediolateral, ML, from
the sagittal axis; −3.55 mm rostrocaudal, RC, from bregma; 3.8 mm dorsoventral,
DV). For brain acute slice preparation, after a lethal injection of thiopental (50 mg
i.p.; RotexMedica, GMBH, Germany), rats were intracardially perfused with ice-
cold, modiﬁed Ringer solution adapted for cutting (119 mM NaCl, 2.5 mM KCl,
1 mM CaCl2, 3 mM MgSO4, 26.2 mM NaHCO3, 1 mM NaH2PO4, 11 mM D-glu-
cose) bubbled with 95% O2 and 5% CO2, and containing 5000 IU l−1 heparin
(Pharmatex, Milano, Italy). After decapitation, brains were quickly removed and
transferred to ice-cold modiﬁed Ringer. After dissection of the right hippocampus,
transverse slices (450 μm thick) were cut using a tissue chopper (Stoelting, Wood
Dale, IL), submerged in the above solution adapted for recording (2 mM CaCl2 and
1.3 mM MgSO4), warmed at 33.6 °C for 1 h and then maintained at room tem-
perature up to 6 h. For SB uptake experiments, acute slices were placed on the slice
recording chamber positioned under the microscope and extracellularly perfused
with the above recording solution (24 °C, bubbled with 95% O2 and 5% CO2). SB
(5 nM) was directly added to the extracellular solution, modiﬁed by the addition of
30 mM KCL (isosmotic).
Electrophysiological recordings and FM1–43 experiments. Cultured neurons
were used for electrophysiological experiments 10–21 days after plating. All
electrophysiological recordings were obtained using WC patch clamp (current-
clamp or voltage-clamp conﬁguration) and neurons were continuously superfused
(1–2 ml min−1) at room temperature (24 °C) with a Tyrode solution containing (in
mM): 119 NaCl, 5 KCl, 2 CaCl2, 2 MgCl2, 25 HEPES, and 30 D-glucose (osmolarity
305 mOsm, pH 7.4). For miniature currents recordings, this solution was supple-
mented with the voltage-gated sodium channel blocker TTX (1 µM; Latoxan,
Valence, France). For SB uptake experiments in current-clamp, bath was supplied
with the NMDA receptor blocker D-2-amino-phosphonovalerate (APV; 25 µM;
Tocris Cookson, Bristol, UK) and the AMPA receptor antagonist 6-cyano-7-
nitroquinoxaline-2,3-dione (CNQX; 10 µM; Tocris Cookson, Bristol, UK) to inhibit
network activity. Patch pipette electrodes (resistance 5–10MΩ) were ﬁlled with an
intracellular solution containing (in mM): 110 D-gluconic acid, 5 MgCl2, 10 NaCl,
0.6 Ethylene glycol-bis(2-aminoethylether)-N,N,N,N-tetraacetic acid (EGTA), 2
ATP, 0.2 GTP, and 49 HEPES (pH adjusted to 7.2 with CsOH; osmolarity
290 mOsm). When testing evoked transmission between neuron pairs CNQX was
not applied to the bath and the pipette patching the presynaptic neuron was ﬁlled
with a K-gluconate solution containing (in mM): 120 K-D-Gluconate, 20 KCl, 2
MgCl2, 0.2 EGTA, 10 HEPES, 0.2 GTP-Na2, 2 ATP-Na2 (pH adjusted to 7.2 with
KOH; osmolarity 290 mOsm), while QX-314 was added to the pipette patching the
postsynaptic neuron (1.5 mg ml−1, Tocris Cookson, Bristol, UK). Current-clamp
recordings were obtained with an EPC7 ampliﬁer (HEKA Elektronik, Lambrecht/
Pfalz, Germany; membrane potential maintained at ~ −75 mV to reduce sponta-
neous action potential ﬁring). Evoked and miniature currents were acquired in
voltage-clamp (holding potential −70 mV; Axopatch 200B or 200A ampliﬁer; Axon
Instruments, Foster City, CA). Membrane and series resistances were constantly
monitored by applying 2–5 mV depolarizing pulses (recordings with series resis-
tance higher than 20MΩ were discarded). All traces were ﬁltered at 2–5 kHz and
digitally acquired at 20 kHz using a 16-bit analog-to-digital interface (ITC-18;
HEKA Elektronik, Lambrecht/Pfalz, Germany) controlled by custom acquisition
software (Labview and C/C++). Analysis of recordings was performed with custom
code developed in Matlab (Mathworks; miniature detection algorithm as previously
described51). In vivo recordings of visual evoked potentials (PEVs) were performed
on Sprague Dawley rats (300–350 g) under general anesthesia (sevoﬂurane 3.5%)
by measuring electro-cortical activity through screws implanted in the skull26. For
FM1–43 experiments, synapses were labeled for 1–2 min with 10 μM FM1–43
(Molecular Probes—Thermo Fisher) dissolved in modiﬁed Tyrode solution (iso-
tonic 90 mM KCl; 10 μM CNQX; APV 25 μM). After 15 min of perfusion with a
washing Tyrode solution (10 μM CNQX; APV 25 μM; TTX 1 μM), unloading was
obtained in a standard Tyrode solution (10 μM CNQX; APV 25 μM) by ﬁeld
stimulation using two parallel Platinum electrodes (constant current stimulation,
40 mA/cm; 10 APs trains at 10 Hz, 4 s inter-train interval).
Anesthesia and stereotaxic surgery. Anesthesia was induced by inhalation of 5%
sevoﬂurane in an induction chamber (Abbvie, North Chicago, IL, USA) until the
animal was unconscious, based on loss of the righting reﬂex. Anesthesia was
maintained by injection of ketamine/xylazine (50 mg/kg; Ketavet 100® Veterifarm;
xylazine 5 mg/kg, Rompun®, Bayer) or, alternatively, by 3.5% sevoﬂurane insuf-
ﬂation into the intubated, mechanically ventilated animal26 (tidal volume 6ml;
respiratory rate 70–80 breaths min−1). Anesthetized animals were then injected
with dexamethasone (0.2 mg/kg s.c.; Dexamethasone Phosphate, Hospira Srl) and
gentamycin (1.5 mg/kg i.p.; Gentamycin Sulphate, Italfarmaco), and an eye oint-
ment (Xantergel®, SIFI S.p.a) was applied bilaterally to prevent drying. For ste-
reotaxis the skull was disinfected with 2% Chlorhexidine (CITROclorex 2%®,
Esoform) and Betadine (Eso jod 10%®, Esoform). A custom-made stereotactic
apparatus52 was used for LV or SB delivery into brain. For injection, glass
micropipettes (60 μm tip diameter; borosilicate, VWR International) were front-
ﬁlled and connected with a P10 Teﬂon tube to a 50 µL Hamilton micro-syringe pre-
ﬁlled with mineral oil, operated by a motor-driven micro-perfusion system (100 nl
min−1; Harvard Apparatus Pump 11 Elite). At the end of stereotaxic delivery,
sutures were placed under anesthesia, the animal returned to cage and the recovery
and health state monitored. For viral transduction, LV particles in PBS (~109 TU
ml−1 LV; 6 µl of PBS solution supplemented with 0.3 M mannitol53) were injected.
Before pipette withdrawal, the micro-pipette was left in place for 10 min to allow
for diffusion of LV particles. For visual experiments, LV particles were injected into
the right dLGN (3.65 mm ML, −4.35 mm RC from bregma, 5.20 mm DV) under
ketamine/xylazine anesthesia. For mPFC experiments, LV particles were delivered
into the mPFC (0.65 mm ML, +3.5 mm RC, 3.5 mm DV coordinates) under
sevoﬂurane anesthesia.
In vivo SB uptake experiments. A balance between subjects design without
randomization was adopted for all in vivo SB uptake experiments. In most
experiments, two animals were tested a day and their temporal order was reversed
the next session (for example, control animal before/after light stimulated animal).
For experiments on the visual system, all phases were run with animals fully
anaesthetized as described above. 2–3 weeks from viral transduction, in the pre-
paratory phase, the animal was blindfolded bilaterally in order to prevent exposure
to ambient light during surgery and micro-pipette placement. Stereotaxic coordi-
nates for SB delivery were: V1, 2.85 mm ML; −7.35 mm RC; 0.8 mm DV. For these
experiments we used SB-Alexa647, 13.3 μM dissolved in standard Tyrode solution
(30 min; 100 nl min−1). During SB perfusion control animals were maintained in
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complete darkness. Light-stimulated animals were initially kept in complete
darkness (15 min), then their left eye was unblinded and light pulses were admi-
nistered for the subsequent 15 min. Light stimulation was delivered using a white
LED matrix placed at a distance of 1.2 cm from the eye (250 ms pulse duration;
340 μW irradiance; 2 Hz stimulation rate). For mPFC experiments, animals fully
anaesthetized as described above were locally perfused with a bolus of SB (SB-
Alexa647, 1.9 μM dissolved in standard Tyrode solution; 30 min; 100 nl min−1) at
coordinates 0.65 mm ML, +3.5 mm RC, 2.8 mm DV; after micro-pipette removal
and re-suturing (see above). Animals were waken up and left freely moving in cages
for 1.5 h. For drug treatments, ketamine (15 mg/kg) or vehicle were i.p. adminis-
tered either immediately after the end of micro-perfusion of SB-Alexa647 (animal
was still under anesthesia), or 72 h before micro-perfusion of SB-Alexa647. At the
end of perfusion, animals still under general anesthesia were sacriﬁced with a lethal
dose of Thiopental (Thiopental, Vuab-Pharma) and then intracardially perfused
with cold saline supplemented with heparin (5000 IU l−1), followed by PFA 4% in
120 mM phosphate buffer (pH 7.4 at 4 °C). The brain was removed, submerged in
ﬁxative O/N (4 °C), embedded in 4% agar. 35–40 µm thick slices were cut with a
vibratome (VT1000S, Leica, Germany), when required processed for immuno-
ﬂuorescence, then mounted onto glass slides (Fluorsave, EMD Millipore). For
detection of PSD95A, we used the method by Schneider et al.54 on unﬁxed 15 µm
thick slices (Cryostat sectioning; CM 1850, Leica, Germany).
Behavioral analysis. For behavioral experiments a balanced within subjects design
without randomization was adopted. Rats were placed in a behavioral cage and
their motility monitored after their awaking from sevoﬂurane anesthesia, in con-
ditions fully matching in vivo SB experiments. The behavioral cage was composed
of the rat’s home cage bottom (38 × 22 cm2) and a custom-built roof hosting a
digital camera for video recording (1280 × 720 pixel2 resolution, 25 fps, NoIR v2
camera controlled by Raspberry Pi 3, Raspberry Pi Foundation). Food and water
were always provided during sessions (water dispenser in the top-right corner;
room temperature 23 °C, low light illumination). Rats were subjected to four video
recording sessions each lasting 90 min (day 0: preconditioning to behavioral cage;
day 1: control recording; day 2: recording after ketamine administration; day 5:
recording 72 h after ketamine administration). Ketamine was administered during
anesthesia (i.p., 15 mg/kg). Tracking and analysis of rat movement were performed
using custom software (Python and Matlab). A pause was considered as a period of
time where rat barycenter remained conﬁned for more than 10 s in a circular area
(2 cm radius). The central area crossing index used an area at the center of the cage
with dimensions 19 cm × 11 cm.
Immunoﬂuorescence. Cells and tissue samples were ﬁxed (4% PFA), quenched
(0.1 M glycine, 120 mM phosphate buffer, pH 7.4, 30 min, 4 °C), and permeabilized
in blocking buffer (0.4% Saponin for cell cultures, 3% Triton X-100 for brain slices;
120 mM phosphate buffer, 1% BSA, pH 7.4, 1 h, 4 °C). Samples were then incu-
bated with primary antibody (1:100–1:300 v/v in blocking buffer; 1–2 h at 23 °C or
O/N at 4 °C) followed by secondary antibody (1:200 v/v in blocking buffer, 1–2 h at
23 °C). Samples were washed with blocking buffer (4 °C), rinsed in PBS, and
mounted (Fluorsave, EMD Millipore). Primary antibodies used: anti-PSD95
(mouse IgG2a, monoclonal; clone 7E3-1B8, Merck Millipore), anti-c-Myc (mouse
monoclonal clone 9E10; Abcam, Cambridge, UK), anti-GAD 65 (mouse IgG2a,
monoclonal; clone GAD-6; Sigma), anti-p38 synaptophysin48 (mouse IgG1,
monoclonal; clone 7.2; Synaptic Systems, Goettingen, Germany), anti-GluR-1
(rabbit polyclonal; generated in house), anti-SNAP25 (rabbit polyclonal; cat.
111002, Synaptic Systems), anti-p65 synaptotagmin (rabbit and goat polyclonal46),
anti-GFP (rabbit polyclonal; cat. A6455, Thermo Fisher Scientiﬁc). Secondary
antibodies used: Donkey anti-Mouse, anti-Rabbit, and anti-Goat AlexaFluor488/
568/647 (Jackson ImmunoResearch).
Image acquisition and data analysis. All ﬂuorescence images (excluding super-
resolution) were obtained using a confocal microscope (LSM510, Zeiss) equipped
with 488, 543, and 633 nM laser lines and standard ﬁlter sets for FITC, TRITC, and
CY5 excitation/emission spectra. In preliminary experiments we evaluated the
range of acquisition parameters (pinhole size, laser power, and detector gain) best
suited to each experimental condition, in order to favor signal to noise ratio while
preserving linearity and avoid signal saturation. Typhoon800 data acquisition was
performed on all brain sections (Supplementary Fig. 6) to identify the SB injection
site. At the beginning of confocal imaging acquisition, low-magniﬁcation scanning
(10× objective) was carried out on slices to evaluate GZ expression and locate the
highest SB intensity spot and select the appropriate areas for the high-
magniﬁcation acquisition step (63× objective; Supplementary Fig. 8). No relevant
information about SB uptake by synapses could be discerned at low magniﬁcation.
The high-magniﬁcation step to acquire images from synaptic areas (as well as later
selection of mPFC axons) was performed using the GZ signal as reference, so that
no information about the functional signal (SB uptake) was known by experi-
menter. Image analysis was performed using either ImageJ (NIH) or custom code
developed in Matlab (Mathworks). All numerical analyses were then performed in
Matlab (Mathworks) or Origin (OriginLab).
For experiments with Hela cells, cell-contours were segmented based on GZ
ﬂuorescence (or on SB-Alexa647 ﬂuorescence when expressing SZ lacking eGFP).
Hela vesicles were identiﬁed by the Particle Analyzer plugin of ImageJ using
thresholding parameters based on the average and SD of vesicle size, roundness,
and ﬂuorescence. For Hela vesicles ﬂuorescence thresholding, background noise
was measured in vesicle-free regions near the plasma membrane using a circular
ROI with similar radius and ﬂuorescence thresholds were then set to mean
background ﬂuorescence plus 2 SD. For cultured neurons experiments, confocal
time-lapse recordings (interval 10 s) were ﬁltered by median and Kalman ﬁlters
(equalized for producing color maps). Synapses belonging to the same axon were
manually selected on the GZ channel and automatically segmented in each frame.
SB and GZ ﬂuorescence were averaged at each synapse and their ratio taken as
normalized SB uptake. The time series produced was ﬁltered (moving average on
four samples) after removing the initial baseline (no SB in the bath). For super-
resolution localization of SB uptake in synaptic vesicles, we used a GSD microscope
(SR GSD 3D, Leica Microsystems, Buffalo Grove, IL), the PALMsiever Matlab
toolbox was then used to generate images from localization lists (kernel density
estimation, pixel size set to 4.12 nm). Standard Matlab functions were utilized for
circle segmentation and measurements of vesicle diameters (synapse contours were
manually traced using the eGFP low-resolution image).
For in vivo experiments, synapses were automatically identiﬁed and segmented
based on GZ ﬂuorescence. A few animals were not included in the analysis when
GZ viral transduction was below detection (lack of a signiﬁcant eGFP signal in
neuronal somata at the site of transduction; Nexcluded/Ntot: V1, 5/15; mPFC, 6/24).
Due to discrepancies in tissue morphology, different approaches were used for V1
and mPFC experiments. In the former case, synapses were segmented using a
custom algorithm based on image thresholding, Voronoid tessellation and then
selected based on shape and ﬂuorescence intensity (threshold: 2 SD of background
noise). In V1 experiments, synapses were considered active when average SB
ﬂuorescence was higher than background SB ﬂuorescence plus 1 SD. In mPFC
experiments, synapses were segmented using the median ﬁltered GZ channel by a
custom algorithm based on image local contrast equalization, image thresholding,
and then selected based on their radius. In these mPFC experiments, to avoid any
misdetection due to the sporadic presence of GZ expressing somata (local
transduction), synapses were accepted for quantitative estimates only when
positioned along putative axons (visually identiﬁed as short sequences of GZ
ﬂuorescing boutons connected by an inter-bouton axonal structure). The
normalized SB uptake index was computed at the level of each individual synapse
as the ratio of SB uptake and GZ expression, both background subtracted. SB and
GZ synaptic ﬂuorescence values were expressed as averages over segmented areas,
while the corresponding signal background referred to the surrounding
ﬂuorescence (circular region around each segmented synapse). For population
comparisons, the index of interest (V1: number of active synapses; mPFC:
normalized SB uptake) was averaged among different ﬁelds of view each coming
from the same subject (V1: 2–5 ﬁelds/rat; mPFC: 3 ﬁelds/rat). In most experiments
acquisition parameters were kept constant. For those experiments where they had
to be modiﬁed, a linear de-trend was applied to the index of interest (trend
estimated on the same experimental group; independent variable: detector gain or
detector gain times laser power). All pseudo-color representations of SB
ﬂuorescence for the in vivo experiments (color maps) here presented have not been
equalized for the sake of comparability. All custom software used for the analysis
can be provided upon request.
Statistical analysis. All statistical analysis was done by routines written in Matlab
(Mathworks) and R or using Origin (OriginLab). Student’s t-test (paired or
unpaired; always two-tailed) was used only after testing for normality by one-
sample KS test. Two-sample KS test was used to evaluate differences between
distributions of ﬂuorescence data sets. Minimum level of signiﬁcance was set at 5%.
Permutation tests for independent samples (104 permutations; two-tailed) were
performed as previously described55. B-H correction of p-values was applied for
multiple comparisons. For both in vitro and in vivo investigations, preliminary
experiments were run to evaluate the expected degree and variability of SB uptake
and establish the most adequate sample size, with the aim of both reaching a
meaningful statistical power and minimizing the number of animals involved in the
study. The ﬁnal set of in vitro and in vivo results showed large SB uptake to noise
ratios, indicating that the initial estimates were appropriate (for example, the
normalized effect size for V1: 4.0; mPFC acute ketamine: 3.56; power> 0.999).
Error bars plot SD or s.e.m. as indicated in the text.
Data availability. The eGFP-SynaptoZip (GZ) cds sequence used in this study has
been deposited at GenBank® with the accession code MF797884 (http://www.ncbi.
nlm.nih.gov/Genbank). DNA constructs and data that support the ﬁndings of this
study are available from the corresponding author upon reasonable request.
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